• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性乳腺癌风险增加的女性采用不同风险管理策略后的心理社会结局:一项关于患者及伴侣结局的混合方法研究

Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes.

作者信息

Morgan J, MacInnes E, Erskine S, Walters S J, Cook J, Collins K, Wyld L

机构信息

University of Sheffield, UK.

Leeds Teaching Hospitals NHS Foundation Trust, UK.

出版信息

Ann R Coll Surg Engl. 2024 Jan;106(1):78-91. doi: 10.1308/rcsann.2023.0042. Epub 2023 Jul 17.

DOI:10.1308/rcsann.2023.0042
PMID:37458196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10757884/
Abstract

INTRODUCTION

Female carriers of genes have an increased lifetime risk of breast cancer. Options for managing risk include imaging surveillance or risk-reducing surgery (RRS). This mixed methods study aimed to identify factors affecting risk-management decisions and the psychosocial outcomes of these decisions for high-risk women and their partners.

METHODS

Semi-structured qualitative interviews were performed with women at high breast cancer risk who had faced these choices. Partners were also interviewed. Analysis used a framework approach. A bespoke questionnaire was developed to quantify and explore associations.

RESULTS

A total of 32 women were interviewed. Of these, 27 had partners of whom 7 (26%) agreed to be interviewed. Four main themes arose: perception of risk and impact of increased risk; risk-management strategy decision-making; impact of risk-management strategy; support needs and partner relationship issues. The questionnaire response rate was 36/157 (23%). Decision satisfaction was high in both surveillance and RRS groups. Relationship changes were common but not universal. Common causes of distress following RRS included adverse body image changes. Both groups experienced generalised and cancer-specific anxiety. Drivers for surgery included having children, deaths of close family from breast cancer and higher levels of cancer anxiety.

CONCLUSIONS

Levels of psychosocial and decision satisfaction were high for women choosing both RRS and surveillance but, for a minority, risk-reducing measures result in long-term psychosocial morbidity. Efforts to recognise women at increased risk of psychological morbidity may allow targeted support.

摘要

引言

携带相关基因的女性患乳腺癌的终生风险增加。管理风险的选择包括影像监测或降低风险手术(RRS)。这项混合方法研究旨在确定影响风险管理决策的因素以及这些决策对高危女性及其伴侣的心理社会结果。

方法

对面临这些选择的高乳腺癌风险女性进行了半结构化定性访谈。其伴侣也接受了访谈。分析采用了框架方法。开发了一份定制问卷以量化和探索关联。

结果

共访谈了32名女性。其中,27名有伴侣,7名(26%)伴侣同意接受访谈。出现了四个主要主题:对风险的认知及风险增加的影响;风险管理策略决策;风险管理策略的影响;支持需求及伴侣关系问题。问卷回复率为36/157(23%)。监测组和RRS组的决策满意度都很高。关系变化很常见但并非普遍存在。RRS后痛苦的常见原因包括身体形象的不良变化。两组都经历了广泛性焦虑和癌症特异性焦虑。手术的驱动因素包括生育、近亲因乳腺癌死亡以及更高水平的癌症焦虑。

结论

对于选择RRS和监测的女性来说,心理社会和决策满意度水平都很高,但对少数人而言,降低风险措施会导致长期的心理社会疾病。识别心理疾病风险增加的女性的努力可能会带来有针对性的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/dff71dbc5aef/rcsann.2023.0042.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/685a5c37324e/rcsann.2023.0042.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/20c27fc475ea/rcsann.2023.0042.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/4262d04e5289/rcsann.2023.0042.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/d9c2875d3b71/rcsann.2023.0042.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/dff71dbc5aef/rcsann.2023.0042.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/685a5c37324e/rcsann.2023.0042.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/20c27fc475ea/rcsann.2023.0042.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/4262d04e5289/rcsann.2023.0042.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/d9c2875d3b71/rcsann.2023.0042.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10757884/dff71dbc5aef/rcsann.2023.0042.05.jpg

相似文献

1
Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes.家族性乳腺癌风险增加的女性采用不同风险管理策略后的心理社会结局:一项关于患者及伴侣结局的混合方法研究
Ann R Coll Surg Engl. 2024 Jan;106(1):78-91. doi: 10.1308/rcsann.2023.0042. Epub 2023 Jul 17.
2
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
3
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
4
A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre.用于评估 BRCA 致病性变异携带者癌症风险管理效果的微观模拟模型:miBRovaCAre。
Value Health. 2019 Aug;22(8):854-862. doi: 10.1016/j.jval.2019.03.008. Epub 2019 May 17.
5
Psychological distress and decision-making factors for prophylactic bilateral mastectomy in cancer-unaffected BRCA1/2 pathogenic variant carriers.癌症未受累的BRCA1/2致病基因变异携带者进行预防性双侧乳房切除术的心理困扰及决策因素
Psychooncology. 2023 Apr;32(4):640-648. doi: 10.1002/pon.6111. Epub 2023 Mar 7.
6
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).对选择进行BRCA1和BRCA2基因症状前检测的女性的一年随访:检测结果的情感影响及风险管理决策(监测或预防性手术)
Breast Cancer Res Treat. 2002 May;73(2):97-112. doi: 10.1023/a:1015269620265.
7
Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.BRCA基因阳性患者降低乳腺癌风险的决策:一项单机构观察性研究
J Womens Health (Larchmt). 2017 Jun;26(6):702-706. doi: 10.1089/jwh.2016.5931. Epub 2016 Dec 6.
8
Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.BRCA1/BRCA2 检测的长期心理社会结局:受影响状态和降低风险手术选择的差异。
Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):445-55. doi: 10.1158/1055-9965.EPI-11-0991. Epub 2012 Feb 10.
9
Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.患者报告结局测量指标可优化 BRCA 基因突变携带者的癌症风险管理中的共享决策。
Breast Cancer. 2020 May;27(3):426-434. doi: 10.1007/s12282-019-01033-7. Epub 2019 Dec 12.
10
Factors that impact risk management decisions among women with pathogenic variants in moderate penetrance genes associated with hereditary breast cancer.影响携带中度外显率基因致病变异体的女性进行风险管理决策的因素,这些基因与遗传性乳腺癌相关。
J Genet Couns. 2020 Dec;29(6):960-970. doi: 10.1002/jgc4.1220. Epub 2020 Feb 3.

引用本文的文献

1
Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.双侧降低风险乳房切除术对乳腺癌高危患者的短期患者报告结局:一项系统评价
Ann Surg Oncol. 2025 Apr;32(4):2510-2525. doi: 10.1245/s10434-024-16805-5. Epub 2025 Jan 4.
2
"Peace of Mind" After Mastectomy: A Scoping Review.《乳腺癌术后“心安”:探索性综述》。
Ann Surg Oncol. 2024 Aug;31(8):5168-5179. doi: 10.1245/s10434-024-15360-3. Epub 2024 May 8.

本文引用的文献

1
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.降低风险的输卵管卵巢切除术、自然绝经与乳腺癌风险:BRCA1 和 BRCA2 突变携带者的国际前瞻性队列研究。
Breast Cancer Res. 2020 Jan 16;22(1):8. doi: 10.1186/s13058-020-1247-4.
2
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
3
Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.
探究男性对与携带BRCA1/2基因突变的女性建立伴侣关系及性行为的态度。
J Genet Couns. 2016 Apr;25(2):290-7. doi: 10.1007/s10897-015-9870-4. Epub 2015 Aug 8.
4
Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis.BRCA1和BRCA2基因突变携带者的双侧预防性乳房切除术:一项荟萃分析。
Ann Surg Oncol. 2015 Sep;22(9):2876-80. doi: 10.1245/s10434-015-4532-1. Epub 2015 Mar 26.
5
Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.具有较高家族性乳腺癌和/或卵巢癌风险的未患病女性进行降低风险手术的长期结果。
Fam Cancer. 2015 Mar;14(1):105-15. doi: 10.1007/s10689-014-9759-7.
6
Findings of a national comparative audit of mastectomy and breast reconstruction surgery in England.英国全国乳房切除术和乳房重建手术比较审计结果。
J Plast Reconstr Aesthet Surg. 2014 Oct;67(10):1333-44. doi: 10.1016/j.bjps.2014.04.022. Epub 2014 May 14.
7
Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.BRCA意义未明变异检测呈阳性的女性与已知BRCA有害突变的女性之间风险管理策略的比较。
Genet Med. 2014 Dec;16(12):896-902. doi: 10.1038/gim.2014.48. Epub 2014 May 22.
8
A systematic review of men's experiences of their partner's mastectomy: coping with altered bodies.对男性伴侣乳房切除术经历的系统评价:应对身体变化
Psychooncology. 2014 Sep;23(9):963-74. doi: 10.1002/pon.3556. Epub 2014 May 7.
9
Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.BRCA1/2 突变携带者进行降低风险手术后的长期满意度和生活质量。
Hered Cancer Clin Pract. 2014 Apr 2;12(1):9. doi: 10.1186/1897-4287-12-9.
10
MRI breast screening in high-risk women: cancer detection and survival analysis.高危女性的乳腺MRI筛查:癌症检测与生存分析
Breast Cancer Res Treat. 2014 Jun;145(3):663-72. doi: 10.1007/s10549-014-2931-9. Epub 2014 Apr 1.